Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Myositis × Rituximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 342 Lymphoma 328 Lymphoma, Non-Hodgkin 286 Leukemia, Lymphocytic, Chronic, B-Cell 264 Lymphoma, Follicular 251 Lymphoma, Mantle-Cell 184 Lymphoma, B-Cell, Marginal Zone 133 Leukemia 107 Burkitt Lymphoma 94 Waldenstrom Macroglobulinemia 87 Lymphoma, B-Cell 87 Precursor Cell Lymphoblastic Leukemia-Lymphoma 78 Recurrence 70 Hodgkin Disease 52 Lymphoma, Large-Cell, Immunoblastic 49 Neoplasms 32 Myelodysplastic Syndromes 24 Multiple Myeloma 23 Leukemia, Myeloid, Acute 23 Dendritic Cell Sarcoma, Interdigitating 21 Leukemia, Hairy Cell 18 Hematologic Neoplasms 18 Lymphoma, Large-Cell, Anaplastic 17 Leukemia, Prolymphocytic 14 Neoplasms, Plasma Cell 12 Intraocular Lymphoma 12 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10 Leukemia, Myelomonocytic, Chronic 10 Leukemia, Myeloid, Accelerated Phase 10 Hematologic Diseases 10

Interventions

Immune Checkpoint Inhibitors 2 Rituximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00774462 2012-12-11

FORCE

Assistance Publique - Hôpitaux de Paris

Phase 2 Completed

Myasthenia Gravis, Myositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡